8-Azaguanine
Names
IUPAC names
5-amino-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one;
[ 1] 5-amino-1,4-dihydro-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one;
[ 2] 3-amino-2,4,7,8,9-pentazabicyclo[4.3.0]nona-1,3,6-trien-5-one
[ 3]
Identifiers
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard
100.004.681
EC Number
RTECS number
UNII
InChI=1S/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11)
Y Key: LPXQRXLUHJKZIE-UHFFFAOYSA-N
Y InChI=1/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11)
Key: LPXQRXLUHJKZIE-UHFFFAOYAO
Properties
C 4 H 4 N 6 O
Molar mass
152.117 g·mol−1
Appearance
white to off-white crystalline powder[ 4]
Density
2.64 g/cm3
Melting point
> 300 °C (decomp. )
Insoluble
Hazards
Flash point
129.1 °C (264.4 °F; 402.2 K)
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
Chemical compound
8-Azaguanine is a purine analog with the chemical formula C4 H4 N6 O. It has been widely studied for its biological activity .[ 5] It shows antineoplastic activity and has been used in the treatment of acute leukemia .[ 2]
Use in chemotherapy
The compound closely resembles guanine and appears to be competitive with it in the metabolism of living organisms .[ 6] It has been shown to cause retardation of some malignant neoplasms when administered to tumors in animals.[ 6] 8-Azaguanine was the first purine analogue discovered to inhibit experimental tumors in mice.[ 7]
Synonyms
2-Amino-6-hydroxy-8-azapurine
2-Amino-6-oxy-8-azapurine
5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one
5-Amino-1,6-dihydro-7H-v-triazolo(4,5-d)pyrimidin-7-one
5-Amino-1H-triazolo(4,5-d)pyrimidin-7-ol
5-Amino-1H-v-triazolo(d)pyrimidin-7-ol
5-Amino-1H-(1,2,3)Triazolo(4,5-d)pyrimidin-7-ol
5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine
7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro- (9CI)
7H-1,2,3-Triazolo(4,5-d)pyrimidinone, 5-amino-1,4-dihydro-
7H-v-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,6-dihydro-
8 AG
8azaG
Azaguanine
Azaguanine-8
Azan
AZG
B-28
Guanazol
Guanazolo
NSC-749
Pathocidin
Pathocidine
SF-337
SK 1150
Triazologuanine
v-Triazolo(4,5-d)pyrimidin-7-ol,5-amino-
* Sources:[ 3] [ 8] [ 9]
References
^ "Azaguanine - Compound Summary (Descriptors)" . National Center for Biotechnology Information . 27 March 2005. Retrieved 2009-03-03 .
^ a b "8-azaguanine" . Mondofacto. 12 December 1998. Archived from the original on 2010-02-15. Retrieved 2009-03-03 .
^ a b "134-58-7, CAS Number: 3546-41-6" . www.chemindustry.com . Archived from the original on 2011-07-16. Retrieved 2009-03-03 .
^ "8-AZAGUANINE" . ChemicalLAND21.com. Retrieved 2009-03-03 .
^ Tong, George L.; Lee, William W.; Goodman, Leon; Frederiksen, Sune (1965). "Synthesis of some 2′-deoxyribosides of 8-azaadenine". Archives of Biochemistry and Biophysics . 112 (1). University of California: Elsevier: 76 . doi :10.1016/0003-9861(65)90012-3 .
^ a b Colsky, J.; Meiselas, E.L.; Rosen, J.S.; Schulman, I. (1955). "Response of patients with leukemia to 8-azaguanine" (PDF) . Blood . 10 (5): 482– 92. doi :10.1182/blood.V10.5.482.482 . PMID 14363328 .
^ Timmis, G.M.; Williams, Donald Charles (1967). "Chemotherapy of Cancer: the Antimetabolite Approach". Butterworths . University of Michigan: 36.
^ "MSDS 7H-v-Triazolo(4,5-d)pyrimidin-7-one,5-amino-1,6-dihydro- CAS 134-58-7 MSDS * 8 AG * 5-Amino-1,6-dihydro-7H-v-triazolo(4,5-d)pyrimidin-7-one * 5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one * 5-Amino-7-hydroxy-1H-v-triazolo(d)pyrimidine * 5-Amino-1H-v-triazolo(d)pyrimidin-7-ol * Azaguanine * Azaguanine-8 * 8-Azaguanine * Azan * AZG * B-28 * Guanazol * Guanazolo * NSC-749 * Pathocidin * Pathocidine * SF-337 * SK 1150 * Triazologuanine * v-Triazolo(4,5-d)pyrimidin-7-ol, 5-amino- * 7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 5-amino-1,4-dihydro-" . www.chemcas.com . Retrieved 2009-03-03 .
^ "Azaguanine - Compound Summary (Synonyms)" . National Center for Biotechnology Information. 27 March 2005. Retrieved 2009-03-03 .
External links